Category:
Active Pharmaceutical Ingredients
CAS NO:
1025967-78-5
Standard:
USP,JP,
Lifitegrast reduces ocular surface inflammation by antagonism of LFA-1 and is indicated for the treatment of signs and symptoms of DED